Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Advancing Precision Immunotherapy for Stage II Melanoma
January 2025
A recent study has uncovered promising advancements in the fight against Stage II melanoma by introducing a novel biomarker technique, immune Förster resonance energy transfer (iFRET).
Read more
10 Jan 2025
Advancing Precision Immunotherapy for Stage II Melanoma
A recent study has uncovered promising advancements in the fight against Stage II melanoma by introducing a novel biomarker technique, immune Förster resonance energy transfer (iFRET).
8 Jan 2025
UV Radiation and Merkel Cell Cancer Risk
An epidemiological study has shed light on the primary risk factors driving Merkel cell carcinoma (MCC), a rare but aggressive form of skin cancer.
4 Jan 2025
Lebrikizumab As Extended Therapy in Chronic Eczema
Patients with moderate-to-severe atopic dermatitis who did not initially meet response criteria for lebrikizumab at 16 weeks can still achieve improvements with continued therapy, according to a recent clinical trial analysis.
1 Jan 2025
Innovative Psoriasis Trial Boosts Diversity in Clinical Research
The VISIBLE trial sets a benchmark for diversity in psoriasis research, achieving rapid enrollment and valuable data for patients with skin of color.
28 Dec 2024
Current Trends in Pediatric Cosmetic Treatments
The most commonly treated pediatric cosmetic conditions included hypertrophic and traumatic scars, acne, axillary and facial hyperhidrosis.
25 Dec 2024
Examining Physiologic Volar Macules in Diverse Populations
This study highlights the importance of recognizing physiologic volar melanotic macules in clinical practice, particularly in individuals with skin of color
20 Dec 2024
Global Consensus Forms on Low-Dose Oral Minoxidil
An international expert panel of 43 dermatologists has established an expert consensus on the off-label use of low-dose oral minoxidil (LDOM) for treating hair loss.
18 Dec 2024
VISIBLE Study Drives Diversity in Psoriasis Research
In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.
Loading posts...
1
2
3
4
Next »